These emerging therapies , Tirzepatide , represent a remarkable advancement in addressing type 2 diabetes and possibly related ailments . These drugs are categorized as GLP-1 pathway agonists , meaning these substances to emulate the natural GLP-1 hormone , boosting metabolic production and reduc